Aarestrup, F.M. (1995). Occurrence of glycopeptides resistance among Enterococcus fae-cium isolates from conventional and ecological poultry farms. Microbiological Drug Resistance 1, 255-257. Alliance for the Prudent Use of Antibiotics (APUA) (1999). Massachusetts Physician Survey. Available at: physicianSurvey.htm (accessed 10 November 2005). American Academy of Orthopaedic Surgeons (AAOS) (2005). Arthroplasty and Total Joint Replacement Procedures: 1991 to 2003. Available at: wordthml/research/stats/arthroplasty_all.htm (accessed 26 November 2005). Association for Professionals in Infection Control and Epidemiology (APIC) (2006). Mandatory Reporting of Infection Rates, Where does Your State Stand? Available at: Reporting/state_legislation/state_legislation.htm (accessed 10 January 2006). Aubert, G., Carricajo, A., Vautrin, A.C. et al. (2005). Impact of restricting fluoroquinolone prescription on bacterial resistance in an intensive care unit. Journal of Hospital Infection 59, 83-89. Bates, J. (1997). Epidemiology of vancomycin-resistant enterococci in the community and the relevance of farm animals to human infection. Journal of Hospital Infection 37, 89-101.

Bauchner, H., Pelton, S.I. and Klein, J.O. (1999). Parents, physicians, and antibiotic use.

Pediatrics 103, 395-401. Bonten, M.J., Hayden, M.K., Mathan, C. et al. (1996). Epidemiology of colonization of patients and environment with vancomycin-resistant enterococci. Lancet 348, 1615-1619. Bonten, .M.J., Slaughter, S., Ambergen, A.W. et al. (1998). The role of "colonization pressure" in spread of vancomycin-resistant enterococci. Archives of Internal Medicine 158, 1127-1132.

Bonten, M.J., Bergmans, D.C., Speijher, H. and Stobberingh, E.E. (1999). Characteristics of polyclonal endemicity of Pseudomonas aeruginosa colonization in intensive care units. American Journal of Respiratory and Critical Care Medicine 160, 1212-1219. Boyce, J.M. (2001). Consequences of inaction: importance of infection control practices.

Clinical Infectious Diseases 33(Suppl. 3), S133-137. Boyce, J.M., Opal, S.M., Chow, J.W. et al. (1994). Outbreak of multidrug-resistant Enterococcus faecium with transferable VanB class vancomycin resistance. Journal of Clinical Microbiology 32, 1148-1153. Bronzwaer, S.L., Carrs, O., Buchholz, U. et al. (2002). A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerging Infectious Diseases 8, 278-282.

Bruinsma, N., Hutchinson, J.M., van den Bogaard, A.E. et al. (2003). Influence of population density on antibiotic resistance. Journal of Antimicrobial Chemotherapy 51, 385-390.

Capitano, B. and Nicolau, D.P. (2003). Evolving epidemiology and cost of resistance to antimicrobial agents in long-term care facilities. Journal of American Medical Directors Association 4(Suppl), S90-98.

Carmeli, Y., Samore, M.H. and Huskins, C. (1999). The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci. Archives oflnternalMedicine 159, 2461-2468.

Carmeli,Y., Eliopoulos, G.M. and Samore, M.H. (2002). Antecedent treatment with different antibiotic agents as risk factors for vancomycin-resistant Enterococcus. Emerging Infectious Diseases 8, 802-807.

Centers for Disease Control and Prevention (1992). Public health focus: surveillance, prevention, and control of nosocomial infections. Morbidity Mortality Weekly Report 41, 783-787.

Centers for Disease Control and Prevention (2004). Brief report: vancomycin-resistant Stapylococcus aureus - New York, 2004. Morbidity and Mortality Weekly Report 53, 322-323.

Chang, S., Sievert, D.M., Hageman, J.C. etal. (2003). Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. New England Journal of Medicine 348, 1342-1347.

Cohen, M.L. (1992). Epidemiology of drug resistance: implications for a post-antimicrobial era. Science 258, 1050-1055.

Contopoulos-Ioannidis, D.G., Koliofoti, I.D., Koutroumpa, I.C. et al. (2001). Pathways for inappropriate dispensing of antibiotics for rhinosinusitis: a randomized trial. Clinical Infectious Diseases 22, 76-82.

Creative Quotations (2006). (accessed 13 January 2006).

DeFrances, C.J., Hall, M.J. and Podgomik, M.N. (2005). 2003 National Hospital Discharge Survey. Advance Data from Vital Health Statistics 359, 1-20.

Deplano, A., Denis, O., Poirel, L. et al. (2005). Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa. Journal of Clinical Microbiology 43, 1198-1204.

Deresinski, S. (2005). Methicillin-resistant Staphylococcus aureus: an evolutionary, epi-demiologic and therapeutic odyssey. Clinical Infectious Diseases 40, 562-573.

DiazGranados, C.A., Zimmer, S.M., Klein, M. and Jernigan, J.A. (2005). Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible entero-coccal bloodstream infections: a meta-analysis. Clinical Infectious Diseases 41, 327-333.

Diekema, D.J., Pfaller, M.A., Jones, R.N. et al. (1999). Survey of bloodstream infections due to Gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997. Clinical Infectious Diseases 29, 595-607.

Dosh, S.A., Hickner, J.M., Mainous, A.G. and Ebell, M.H. (2000). Predictors of antibiotic prescribing for non-specific upper respiratory infections, acute bronchitis, and acute sinusitis: and UPRnet study. Journal of Family Practice 49, 407-414.

EARSS Management Team (2004). EARSS Annual Report, 2003. European Antimicrobial Resistance Surveillance System. Available at: (accessed 31 October 2005).

Eggimann, P. and Pittet, D. (2001). Infection control in the ICU. Chest 130, 2059-2093.

Emori, T.G., Banerjee, S.N., Culver, D.H. et al. (1991). Nosocomial infections in elderly patients in the United States, 1986-1990. American Journal of Medicine 91(Suppl. 3b), S289-293.

Ena, J., Dick, R.W., Jones, R.N. and Wenzel, R.P. (1993). The epidemiology of intravenous vancomycin usage in a university hospital. A 10-year study. Journal of the American Medical Association 269, 598-602.

Eng, J.V, Marcus, R., Hadler, J.L. et al. (2003). Consumer attitudes and use of antibiotics. Emerging Infectious Diseases 9, 1128-1134.

Evans, R.S., Pestotnik, S.L., Classen, D.C. et al. (1998). A computer-assisted management program for antibiotics and other antiinfective agents. New England Journal of Medicine 338, 232-238.

Fahey, T., Stocks, N. and Thomas, T. (1998). Quantitative systemic review of randomized controlled trials comparing antibiotic with placebo for acute cough in adults. British Medical Journal 316, 906-910.

Farr, B.M. (2000). Reasons for non-compliance with infection control guidelines. Infection Control and Hospital Epidemiology 21, 411-416.

Fauci, A.S. (2001). Infectious diseases: considerations for the 21st century. Clinical Infectious Diseases 32, 675-685.

Feikin, D.R., Schuchat, A., Kolczak, A.M. et al. (2000). Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. American Journal of Public Health 90, 223-229.

Fendrick, A.M., Monto, A.S., Nightengale, B. and Sarnes, M. (2003). The economic burden of non-influenza-related viral respiratory tract infection in the United States. Archives oflnternalMedicine 163, 487-494.

Fridkin, S.K., Pear, S.M., Williamson, T.H. et al. (1996). The role of understaffing in central venous catheter-associated bloodstream infections. Infection Control and Hospital Epidemiology 17, 150-158.

Fridkin, S.K., Edwards, J.R., Courval, J.M. et al. (2001). The effects of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 US adult intensive care units. Annals of Internal Medicine 135, 175-183.

Garibaldi, R.A. (1999). Residential care and the elderly: the burden of infection. Journal of Hospital Infection 43(Suppl.), S9-18.

Goldmann, D.A., Leclair, J. and Macone, A. (1978). Bacterial colonization of neonates admitted to an intensive care environment. Journal of Pediatrics 93, 288-293.

Goni-Urriza, M., Capdepuy, M., Arpin, C. et al. (2000). Impact of an urban effluent on antibiotic resistance of riverine Enterobacteriaceae and Aeromonas spp. Applied Environmental Microbiology 66, 125-132.

Gonzales, R., Steiner, J.F., Lum, A. and Parrett, P.H. (1999). Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. Journal of the American Medical Association 281, 1512-1519.

Gonzales, R., Malone, D.C., Maselli, J.H. and Sande, M. (2001). Excessive antibiotic use for acute respiratory infections in the United States. Clinical Infectious Diseases 33, 757-762.

Graves, E.J. (1995). Detailed diagnoses and procedures: National Hospital Discharge Survey, 1993. Vital Health Statistics 13(122).

Gross, P.A., Papuano, C., Adrignola, A. and Shaw, B. (1983). Nosocomial infections: decade-specific risk. Infection Conrol4, 145-147.

Guillemot, D., Maison, P., Carbon, C. et al. (1997). Trends in antimicrobial drug use in the community - France, 1981-1992. Journal of Infectious Diseases 177, 492-497.

Gupta, A., Nelson, J.M., Barrett, T.J. et al. (2004). Antimicrobial resistance among Campylobacter strains, United States, 1997-2001. Emerging Infectious Diseases 10, 1102-1109.

Haley, R.W., Culver, D.H., White, J. et al. (1985). The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. American Journal of Epidemiology 121, 182-205.

Harbarth, S., Cosgrove, S. and Carmeli, Y. (2002a). Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrobial Agents and Chemotherapy 46, 1619-1628.

Harbarth, S., Albrich, W. and Brun-Buisson, C. (2002b). Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective. Emerging Infectious Diseases 8, 1460-1467.

Hayden, M.K., Rezai, K., Hayes, R.A. et al. (2005). Development of daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus. Journal of Clinical Microbiology 43, 5285-5287.

Howard, D.H. and Scott, R.D. (2005). The economic burden of drug resistance. Clinical Infectious Diseases 41(Suppl. 4), S283-286.

Howard, D.H., Scott, R.D., Packard, R. and Jones, D. (2003). The global impact of drug resistance. Clinical Infectious Diseases 36(Suppl, 1), S4-10.

Hutchinson, J.M. and Foley, R.N. (1999). Method of physician remuneration and rates of antibiotic prescription. Canadian Medical Association Journal 160, 1013-1017.

Jacobs, M.R. (2003). Worldwide trends in antimicrobial resistance among common respiratory tract pathogens in children. Pediatric Infectious Diseases Journal 22, S109-119.

Jacobs, M.R., Felmingham, D., Appelbaum, P.C. Gruneberg, R.N. and the Alexander Project Group (2003). The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. Journal of Antimicrobial Chemotherapy 52, 229-246.

Kollef, M.H., Sherman, G., Ward, S. and Fraser, V.J. (1999). Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115, 462-474.

Lautenbach, E., Patel, J.B., Bilker, W.B. et al. (2001). Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clinical Infectious Diseases 32, 1162-1171.

Legras, A., Malvy, D., Quinioux, A.I. et al. (1998). Nosocomial infections: prospective survey of incidence in five French intensive care units. Intensive Care Medicine 24, 1040-1046.

Levy, S. and Marshall, B. (2004). Antibacterial resistance worldwide: causes, challenges and responses. Nature Medicine 10(Suppl.), S122-129.

Livermore, D.M. (2003). Bacterial resistance: origins, epidemiology, and impact. Clinical Infectious Diseases 36(Suppl. 1), S11-23.

Low, D.E. (2005). Changing trends in antimicrobial-resistant pneumococci: It's not all bad news. Clinical Infectious Diseases 41(Suppl. 4), S228-233.

Low, D.E., Keller, N., Barth, A. and Jones, R.N. (2001). Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clinical Infectious Diseases 32(Suppl. 2), S133-145.

MacDougall, C. and Polk, R.E. (2005). Antimicrobial stewardship programs in health care systems. Clinical Microbiology Reviews 18, 638-656.

Malbruny, B., Canu, A., Bozdogan, B. et al. (2002). Resistance to quinupristin-dalfopristin due to mutation of L22 ribosomal protein in Staphylococcal aureus. Antimicrobial Agents and Chemotherapy 46, 2200-2207.

Manikal, V.M., Landman, D., Saurina, G. et al. (2000). Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clinical Infectious Disease 31, 101-106.

McClusker, M.E., Harris, A.D., Perencevich, E. and Roghmann, M.C. (2003). Fluro-quinolone use and Clostridium difficile-associated diarrhea. Emerging Infectious Diseases 9, 730-733.

McDonald, L.C., Kilgore, G.E., Thompson, A. et al. (2005). An epidemic, toxin gene-variant strain of Clostridium difficile. New England Journal of Medicine 353, 2433-2441.

McEwen, S.A. and Fedorka-Cray, P.J. (2002). Antimicrobial use and resistance in animals. Clinical Infectious Diseases 34(Suppl. 3), S93-106.

McGarry, S.A., Engemann, J.J., Schmader, K. et al. (2004). Surgical site infection due to Staphylococcus aureus in the elderly: mortality, duration of hospitalization and cost. Infection Control and Hospital Epidemiology 25, 461-467.

Mellon, M., Benbrook, C. and Benbrook, K. (2001). Hogging It: Estimates of Antimicrobial Abuse in Livestock. Cambridge: UCS Publications.

Merrer, J., Santoli, F., Appere de Vecchi, C. et al. (2000). "Colonization pressure" and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infection Control and Hospital Epidemiology 21, 718-723.

Mosdell, D.M., Morris, D.M. and Voltura, A. (1991). Antibiotic treatment for surgical peritonitis. Annals of Surgery, 214, 543-549.

Mutnick, A.H., Rhomberg, P.R., Sader, H.S. and Jones, R.N. (2004). Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1991-2001). Journal of Antimicrobial Chemotherapy 53, 290-296.

Nasrin, D., Collignon, P.J., Roberts, L. et al. (2002). Effect of beta-lactam antibiotic use in children on pneumococcal resistance to penicillin: prospective cohort study. British Medical Journal 340, 1-4.

National Center for Health Statistics (NCHS) (1996). Number of Ambulatory and Inpatient Procedures by Procedure Category and Location: United States, 1996. Available at: (accessed 26 November 2005).

Nava, J.M., Bella, F., Garau, J. et al. (1994). Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clinical Infectious Diseases 19, 884-890.

Neuhauser, M.M., Weinstein, R.A., Rydman, R. et al. (2003). Antibiotic resistance among Gram-negative bacilli in US intensive care units. Journal of the American Medical Association 289, 885-888.

NNIS System (1998). National Nosocomial Infection Surveillance System Report, Data Summary from October 1986-April 1998, issued June 1998. Available at: http://www. (accessed 26 November 2005).

NNIS System (2004). National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. American Journal of Infection Control 32, 470-485.

Ochoa, C., Eiros, J.M., Inglada, L. et al., Spanish Study Group on Antibiotic Treatments (2000). Assessment of antibiotic prescription in acute respiratory infections in adults. Journal of Infection 41, 73-83.

Ostrowsky, B.E., Trick, W.E., Sohn, A.H. et al. (2001). Control of vancomycin-resistant enterococcus in health care facilities in a region. New England Journal of Medicine 344, 1427-1433.

Paris, M.M., Ramilo, O. and McCracken, G.H. (1995). Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 39, 2171-2175.

Paterson, D.L., Rossi, F., Baquero, F. et al. (2005). In vitro susceptibilities of aerobic and facultative Gram-negative bacilli from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART). Journal of Antimicrobial Chemotherapy 55, 965-973.

Peeters, M.J. and Sarria, J.C. (2005). Clinical characteristics of Linezolid-resistant Staphylococcus aureus infections. American Journal ofMedical Sciences 330, 102-104.

Perchere, J.C. (2001). Patients' interviews and misuse of antibiotics. Clinical Infectious Diseases 33(Suppl. 3), S170-173.

Pestotnik, S.L., Classen, D.C., Evans, R.S. and Burke, J.P. (1996). Implementing antibiotic practice guidelines through computer-assisted decision support: clinical and financial outcomes. Annals of Internal Medicine 124, 884-890.

Phelps, D.E. (1989). Bug/drug resistance. Medical Care 27, 194-203.

Pichichero, M.E. (1999). Understanding antibiotic overuse for respiratory tract infections in children. Pediatrics 104, 1384-1388.

Pinner, R.W., Teutsch, S.M., Simonsen, L. et al. (1996). Trends in infectious diseases mortality in the United States. Journal of the American Medical Association 275, 189-193.

Pittet, D. (2001). Compliance with hand disinfection and its impact on hospital-acquired infections. Journal ofHospital Infection 48(Suppl.), S40-46.

Pittet, D., Hugonnet, S., Harbath, S. et al. (2000). Effectiveness of a hospital-wide program aimed at improving compliance with hand hygiene. Lancet 356, 1307-1312.

Radyowijati, A. and Haak, H. (2002). Determinants of antimicrobial use in the developing world. Child Health Research Project Special Report 4(1), 1-36. Available at: http:// (accessed 14 November 2005).

Roberts, R.R., Scott, R.D., Cordell, R. et al. (2003). The use of economic modeling to determine the hospital costs associated with nosocomial infections. Clinical Infectious Diseases 36, 1424-1432.

Rubin, M.A., Bateman, K., Alder, S. et al. (2005). A multifaceted intervention to improve antimicrobial prescribing for upper respiratory tract infections in a small rural community. Clinical Infectious Diseases 40, 546-553.

Schwartz, B., Mainous, A.G. and Marcy, S.M. (1998). Why do physicians prescribe antibiotics for children with upper respiratory tract infections. Journal of the American Medical Association 279, 881-882.

Seppala, H., Nissinen, A., Jarvinen, H. et al. (1992). Resistance to erythromycin in Group A Streptococci. New England Journal ofMedicine 326, 292-297.

Seppala, H., Klaukka, T., Vuopio-Varkila, J. et al. (1997). The effects of changes in the consumption of macrolide antibiotics on erythromycin resistance in Group A Streptococci in Finland. New England Journal ofMedicine 337, 441-446.

Singh-Naz, N., Sprague, B.M., Patel, K.M. and Pollack, M.M. (1996). Risk factors for nosocomial infection in critically ill children: a prospective cohort study. Critical Care Medicine 24, 875-878.

Smith, K.E., Besser, J.M., Hedberg, C.W. et al. (1999). Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. New England Journal of Medicine 340, 1525-1532.

Strausbaugh, L.J. (2001). Emerging health care-associated infections in the geriatric population. Emerging Infectious Diseases 7, 268-271.

Stroser, V., Peterson, L.R., Postelnick, M. and Noskin, G.A. (1998). Enterococcus fae-cium bacteremia: does vancomycin resistance make a difference? Archives of Internal Medicine 158, 522-527.

Swartz, M.N. (1994). Hospital-acquired infections: diseases with increasingly limited therapies. Proceedings of the National Academy of Science 91, 2420-2427.

Swartz, M.N. (2002). Human diseases caused by foodborne pathogens of animal origin. Clinical Infectious Diseases 34 (Suppl. 3), S111—122.

United States Renal Data System (USRDS) (2005). 2005Annual Data Report, Reference Section D: Treatment Modalities. Available at: (accessed 26 November 2005).

US Congress, Office of Technology Assessment (1995). Impacts of Antibiotic-Resistant Bacteria, OTA-H-629. Princeton: Princeton University. Available at: http://www.wws. (accessed 31 October 2005).

van den Bogaard, A.E., Jensen, L.B. and Stobberingh, E.E. (1997). Vancomycin-resist-ant enterococci in turkeys and farmers. New England Journal of Medicine 337, 1558-1559.

Vilhjalmur, A.A., Kristinsson, K.G., Sigurdsson, J.A. et al. (1996). Do antimicrobials increase the carriage rate to penicillin resistant pneumococci in children? Cross sectional prevalence study. British Medical Journal 313, 387-391.

Vincent, J.L., Bihari, D.J., Suter, P.M. et al. (1995). The prevalence of nosocomial infection in the intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study. Journal of the American Medical Association 274, 639-644.

Wachter, D.A., Joshi, M.P. and Rimal, B. (1999). Antibiotic dispensing by drug retailers in Katmandu, Nepal. Tropical Medicine and International Health 4, 782-788.

Watson, R.L., Dowwell, S.F., Jayaraman, M. et al. (1999). Antimicrobial use for pediat-ric upper respiratory infections: reported practice, actual practice and parent beliefs. Pediatrics 104, 1251-1257.

Weinstein, R.A. (1998). Nosocomial infection update. Emerging Infectious Diseases 4, 416-420.

Weinstein, R.A. (2001). Controlling antimicrobial resistance in hospitals: infection control and the use of antibiotics. Emerging Infectious Diseases 7, 188-192.

Weinstein, R.A., Siegel, J.D. and Brennan, P.J. (2005). Infection control report cards -securing patient safety. New England Journal of Medicine 353, 225-227.

White, A.C., Atmar, R.L., Wilson, J. et al. (1997). Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clinical Infectious Diseases 25, 230-239.

Wisplinghoff, H., Bischoff, T., Tallent, S.M. et al. (2004). Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clinical Infectious Diseases 39, 309-317.

Yoshikawa, T.T. (2000). Epidemiology and unique aspects of aging and infectious diseases. Clinical Infectious Diseases 30, 931-933.

0 0

Post a comment